NM_004721.5:c.-86+31503A>G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004721.5(MAP3K13):c.-86+31503A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.703 in 151,898 control chromosomes in the GnomAD database, including 38,082 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.70   (  38082   hom.,  cov: 30) 
Consequence
 MAP3K13
NM_004721.5 intron
NM_004721.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.891  
Publications
3 publications found 
Genes affected
 MAP3K13  (HGNC:6852):  (mitogen-activated protein kinase kinase kinase 13) The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase contains a dual leucine-zipper motif, and has been shown to form dimers/oligomers through its leucine-zipper motif. This kinase can phosphorylate and activate MAPK8/JNK, MAP2K7/MKK7, which suggests a role in the JNK signaling pathway. [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.767  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.703  AC: 106653AN: 151780Hom.:  38059  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
106653
AN: 
151780
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.703  AC: 106715AN: 151898Hom.:  38082  Cov.: 30 AF XY:  0.702  AC XY: 52124AN XY: 74240 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
106715
AN: 
151898
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
52124
AN XY: 
74240
show subpopulations 
African (AFR) 
 AF: 
AC: 
23168
AN: 
41384
American (AMR) 
 AF: 
AC: 
10810
AN: 
15258
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2807
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
3472
AN: 
5160
South Asian (SAS) 
 AF: 
AC: 
3613
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
7784
AN: 
10518
Middle Eastern (MID) 
 AF: 
AC: 
218
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
52510
AN: 
67968
Other (OTH) 
 AF: 
AC: 
1538
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 1567 
 3134 
 4701 
 6268 
 7835 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 834 
 1668 
 2502 
 3336 
 4170 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2385
AN: 
3470
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.